Skip to main content
. 2010 Jan 12;102(3):475–481. doi: 10.1038/sj.bjc.6605522

Table 2. Best overall response rates in 100 evaluable patients.

  wTCF (%) (95% CI) wTX (%) (95% CI)
Tumour response (n=47) (n=53)
Confirmed complete response 4 0
Confirmed partial response 43 26
Confirmed complete or partial response 47 (32–62) 26 (15–40)
Stable disease 38 53
Progressive disease 15 21

Abbreviations: wTCF=weekly docetaxel plus cisplatin and 5-fluorouracil; wTX=weekly docetaxel plus capecitabine.

HHS Vulnerability Disclosure